Equity Research, Broker Reports, and media content on Shield Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics. We currently have 94 research reports from 8 professional analysts.

Open
N/A
Range Today
N/A
52 Week
30.5/196p
Daily Volume
N/A
# Shares
117.2m
Daily Liquidity
(0.08%)
Pension Liability
£0m
Enterprise Value
£206.4m
Market Cap
£216.8m
Latest PE (hist)
Div Yield
Date Source Announcement
12Dec19 17:30 RNS Eland Oil & Gas
29Nov19 15:31 RNS Holding(s) in Company
25Nov19 07:00 RNS QCA Corporate Governance Code
30Oct19 07:30 EQS Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
22Oct19 07:00 RNS Positive results presented at UEG Week 2019
26Sep19 07:00 RNS-R Investor Presentation
02Sep19 09:14 EQS Hardman & Co Research: Shield Therapeutics (STX): FDA approval ushers in a new era for Shield
  • Frequency of research reports

     

  • Research reports on

    Shield Therapeutics

  • Providers covering

    Shield Therapeutics